Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-20
1986-02-18
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 514274, 2602433, 544284, 544286, 544317, A61K 31505, C07D40112
Patent
active
045713987
ABSTRACT:
This invention relates to cytosine derivatives which have histamine H.sub.2 -antagonist activity. A specific compound of this invention is 4-[3-(3-(piperidinomethyl)phenoxy)propylamino]-pyrimidin-2-thione.
REFERENCES:
patent: 3932644 (1976-01-01), Durant et al.
patent: 4234588 (1980-11-01), Brown et al.
patent: 4374836 (1983-02-01), Yellin et al.
patent: 4385058 (1983-05-01), Cooper et al.
patent: 4463005 (1984-07-01), Jones et al.
Derwent Abstract 38240c (EP 13,071) Jul. 9, 1980.
Foggio Richard D.
Hollrah Glennon H.
Keps Joan S.
Lourie Alan D.
Smith Kline & French Laboratories Limited
LandOfFree
Cytosine derivatives having histamine H.sub.2 -antagonist activi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytosine derivatives having histamine H.sub.2 -antagonist activi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytosine derivatives having histamine H.sub.2 -antagonist activi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1551025